Você está na página 1de 2

EXECUTIVE SUMMARY

Pharmacotherapies indicated for alcohol, narcotic, and nicotine addictions account


for a market estimated at US$2 billion which is forecast to increase 41% CAGR to
US$2.9 billion by 2012 based on the expanded uptake of current and late-stage
development drugs and increasing global prevalence of alcohol, narcotic, and
nicotine dependencies. The introduction of novel therapies for these addiction
disorders, in addition to new pharmacotherapies for methamphetamine,
phencyclidine, and gambling dependencies, are also predicted to significantly
increase the market by a further US$2 billion by 2020.

With over 30 drug candidates in the pipeline for addictions, medical therapies for
these highly prevalent difficult-to-treat conditions are on course for dynamic change.
Novel drugs with unique therapeutic approaches and long-acting reformulations to
combat physical and psychological dependencies will revolutionize addiction
pharmacotherapy interventions over the next 7 years.

In this report, The World Market for Addiction Disorders, 2005-2012: New
Horizons in High-Profile Dependency Markets, the reader will be introduced to a
specialty pharmaceutical market positioned for high-growth based on analysis of
marketed and pipeline drugs, company activities, and addiction disorder
demographics. Furthermore, the briefing comments on strategic and commercial
issues that may affect product positioning and revenue optimization of current
products. The report also discusses key products such as naltrexone reformulations,
nicotine replacement therapies, and novel vaccine therapies that have the potential
to create new market sectors and become high-value products over the next decade.

Therapy area forecasting and illustrative comparative sales data is also presented to
gain insight into leading products with sales estimates to 2012. Forecasting to 2020
is also detailed to enable the reader to make key assumptions about future markets
and prospects, and utilize the data for proprietary predictive market modelling.

7
Objectives of the Report

The objectives of this report are to provide an in-depth analysis of the global
addiction pharmacotherapeutic market. Included in this study are analyses of key
therapy areas, R&D programs, and innovating companies and products. It is hoped
that the reader will benefit from market forecasts, pooled knowledge of recent
industrial activities and events, and from analytical discourse, which is intended to
stimulate growth and create new market opportunities.

Research Methodology

The contents of this report are derived from in-depth research-based surveys of the
industry and proprietary analytical assessment tools. Source material also comprises
the following:

 Company information  Scientific periodicals


 Personal communication  Product information
 Trade press articles  Market analyst data
 News releases  Public information datasets
 Internet-based research  Conference proceedings
 Library research  Medical/pharma associations

Você também pode gostar